FUSION AND AMPLIFICATION OF 2 ORIGINALLY NONSYNTENIC CHROMOSOMAL REGIONS IN A MAMMARY-CARCINOMA CELL-LINE

被引:43
作者
LAFAGE, M
PEDEUTOUR, F
MARCHETTO, S
SIMONETTI, J
PROSPERI, MT
GAUDRAY, P
BIRNBAUM, D
机构
[1] INSERM, U119, MOLEC ONCOL LAB, 27 BD LEI ROURE, F-13009 MARSEILLE, FRANCE
[2] INSERM, U119, MOLEC HEMATOL & CYTOGENET LAB, F-13258 MARSEILLE 09, FRANCE
[3] INST J PAOLI I CALMETTES, CTR ANTICANCEREUX MARSEILLE, F-13009 MARSEILLE, FRANCE
[4] LGMCH, CNRS, URA 1462, NICE, FRANCE
[5] INST CURIE, F-75231 PARIS 05, FRANCE
关键词
D O I
10.1002/gcc.2870050107
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The FLG/FGFRI gene, encoding a receptor for members of the FGF family, is located at 8p11.2-p12. It is amplified, overexpressed, and not grossly rearranged in the MDA-MB-134 breast carcinoma cell line, whereas other genes from the pericentromeric 8p region are not amplified. The FGF4/HSTFI gene, located at 11q13, is also amplified with a substantial portion of the 11q13 region, but is not overexpressed in MDA-MB-134 cells. In this cell line, amplified sequences constitute a large homogeneously staining region (HSR) which is part of a marker chromosome containing chromosome 8 and chromosome 11 sequences. Using probes for the FGF4/HSTFI and the FLG/FGFRI genes in fluorescence chromosomal in situ hybridization, we show that the HSR contains de novo fused and amplified 11q13 and 8p 11-p12 sequences associated in a complex structure containing approximately the same number of FGF4 and FGFRI genes. The significance of this genetic abnormality for MDA-MB-134 cells, and for breast carcinogenesis in general, is unknown, but may underlie a particular type of oncogene activation.
引用
收藏
页码:40 / 49
页数:10
相关论文
共 51 条
[1]  
ADELAIDE J, 1988, ONCOGENE, V2, P413
[2]  
ADNANE J, 1991, ONCOGENE, V6, P659
[3]   LOCALIZATION OF THE FIBROBLAST GROWTH-FACTOR RECEPTOR-4 GENE TO CHROMOSOME REGION 5Q33-QTER [J].
ARMSTRONG, E ;
PARTANEN, J ;
CANNIZZARO, L ;
HUEBNER, K ;
ALITALO, K .
GENES CHROMOSOMES & CANCER, 1992, 4 (01) :94-98
[4]   MOLECULAR THEMES IN ONCOGENESIS [J].
BISHOP, JM .
CELL, 1991, 64 (02) :235-248
[5]   BREAST TUMOR-CELL LINES FROM PLEURAL EFFUSIONS [J].
CAILLEAU, R ;
YOUNG, R ;
OLIVE, M ;
REEVES, WJ .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1974, 53 (03) :661-674
[6]   CHARACTERIZATION AND CHROMOSOME ASSIGNMENT OF THE HUMAN HOMOLOG OF INT-2, A POTENTIAL PROTOONCOGENE [J].
CASEY, G ;
SMITH, R ;
MCGILLIVRAY, D ;
PETERS, G ;
DICKSON, C .
MOLECULAR AND CELLULAR BIOLOGY, 1986, 6 (02) :502-510
[7]   GENOMIC SEQUENCING [J].
CHURCH, GM ;
GILBERT, W .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (07) :1991-1995
[8]  
DEVILEE P, 1990, CANCER SURV, V9, P605
[9]   CLONING AND EXPRESSION OF 2 DISTINCT HIGH-AFFINITY RECEPTORS CROSS-REACTING WITH ACIDIC AND BASIC FIBROBLAST GROWTH-FACTORS [J].
DIONNE, CA ;
CRUMLEY, G ;
BELLOT, F ;
KAPLOW, JM ;
SEARFOSS, G ;
RUTA, M ;
BURGESS, WH ;
JAYE, M ;
SCHLESSINGER, J .
EMBO JOURNAL, 1990, 9 (09) :2685-2692
[10]   CHARACTERIZATION OF CHROMOSOMAL-ANOMALIES IN HUMAN BREAST-CANCER - A COMPARISON OF 30 PARADIPLOID CASES WITH FEW CHROMOSOME CHANGES [J].
DUTRILLAUX, B ;
GERBAULTSEUREAU, M ;
ZAFRANI, B .
CANCER GENETICS AND CYTOGENETICS, 1990, 49 (02) :203-217